J. Vest

发表

A clinical feasibility study of atrial and ventricular electromechanical wave imaging.

E. Konofagou, J. Provost, H. Garan, 2013, Heart rhythm.

Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)

R. Falk, D. Judge, M. Maurer, 2020, Cardiovascular Drugs and Therapy.

DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis

M. Maurer, H. Taylor, J. Gollob, 2020, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study

S. Solomon, A. Shah, M. Maurer, 2019, Circulation.

Clinical Use of Cooled Radiofrequency Ablation

W. Stevenson, J. Seiler, J. Vest, 2008, Journal of cardiovascular electrophysiology.

Discovery of N-[5-(6-Chloro-3-cyano-1-methyl-1H-indol-2-yl)-pyridin-3-ylmethyl]-ethanesulfonamide, a Cortisol-Sparing CYP11B2 Inhibitor that Lowers Aldosterone in Human Subjects.

Lu Gan, J. Vest, G. Ksander, 2015, Journal of medicinal chemistry.

(cid:1) -Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure

D. Burkhoff, D. Mancini, S. Reiken, 2003 .

-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure

D. Burkhoff, D. Mancini, S. Reiken, 2003 .

FKBP12.6 Deficiency and Defective Calcium Release Channel (Ryanodine Receptor) Function Linked to Exercise-Induced Sudden Cardiac Death

S. Priori, J. D’Armiento, M. Memmi, 2003, Cell.

Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis

B. Bettencourt, M. Maurer, W. Blaner, 2016, Journal of Nuclear Cardiology.

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

E. Nordh, Yi-Chung Lee, R. Sommerville, 2020, Lancet Neurology.

Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic for the treatment of patients with transthyretin cardiac amyloidosis

R. Falk, M. Maurer, P. Hawkins, 2015, Orphanet Journal of Rare Diseases.

Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects

M. Sweetser, H. Attarwala, V. Goel, 2020, Clinical pharmacology and therapeutics.

Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

A. González-Duarte, M. Polydefkis, J. Vest, 2022, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Protection from Cardiac Arrhythmia Through Ryanodine Receptor-Stabilizing Protein Calstabin2

Shi-Xian Deng, Donald W. Landry, Daniel Cervantes, 2004, Science.

Gene Silencing Therapeutics in Cardiology: A Review Article

M. Maier, J. Vest, Lisa Duarte, 2021, International Journal of Cardiovascular Sciences.

Steam pops during irrigated radiofrequency ablation: feasibility of impedance monitoring for prevention.

Jens Seiler, W. Stevenson, J. Seiler, 2008, Heart rhythm.

Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation

M. Rosen, P. Danilo, S. Reiken, 2005, Circulation.

Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression.

S. Reiken, A. Marks, S. Lehnart, 2006, Proceedings of the National Academy of Sciences of the United States of America.

&bgr;-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure

D. Burkhoff, D. Mancini, S. Reiken, 2003, Circulation.

Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study.

Giampaolo Merlini, S. Solomon, R. Falk, 2019, JAMA cardiology.

Incessant donor-to-recipient atrial tachycardia after bilateral lung transplantation.

W. Stevenson, F. Sacher, J. Vest, 2008, Heart rhythm.

Atrial Pacing Inducing Narrow QRS Tachycardia Followed By Wide Complex Tachycardia

W. Stevenson, F. Sacher, J. Vest, 2007, Journal of cardiovascular electrophysiology.

Differences in Repeating Patterns of Complex Fractionated Left Atrial Electrograms in Longstanding Persistent Atrial Fibrillation as Compared With Paroxysmal Atrial Fibrillation

Edward J Ciaccio, Angelo B Biviano, William Whang, 2011, Circulation. Arrhythmia and electrophysiology.

Effect of patisiran on stroke volume in hereditary transthyretin‐mediated amyloidosis: insights from pressure–volume analysis of the APOLLO study

M. Maurer, J. Vest, M. White, 2023, European journal of heart failure.

137 PRIMARY RESULTS FROM APOLLO-B, A PHASE 3 STUDY OF PATISIRAN IN PATIENTS WITH TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH CARDIOMYOPATHY

I. Diemberger, M. Maurer, N. Tahara, 2022, European Heart Journal Supplements.

Performance in Human Heart Failure ß-Blockers Restore Calcium Release Channel Function and Improve Cardiac

D. Burkhoff, X. Wehrens, J. Vest, 2003 .

Non-invasive Electromechanical Wave Imaging of atrial, supraventricular and ventricular cardiac conduction disorders in canines and humans

E. Konofagou, J. Provost, H. Garan, 2011, 2011 IEEE International Ultrasonics Symposium.

Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-label extension study.

P. Nioi, S. Ticau, M. Polydefkis, 2023, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

Karla P. Zepeda, Hansie M Mathelier, J. Felius, 2023, Neurology and Therapy.

Recommendations from the Amyloidosis Research Consortium Educational Roundtable at the American College of Cardiology Annual Meeting, 1 April 2016

M. Liedtke, M. Maurer, A. Dispenzieri, 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.